Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ

Experimental Neurology

Volumn 247, Issue , 2013, Pages 113-121

  Pendleton, James C ^a,b   Shamblott, Michael J ^a,b,c   Gary, Devin S ^a,b   Belegu, Visar ^a,b   Hurtado, Andres ^a,b   Malone, Misti L ^a,b   McDonald, John W ^a,b  

^a Hugo W Moser Research Institute   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

CSPG; Demyelination; Oligodendrocyte progenitor cell; Protein tyrosine phosphatase

Indexed keywords

AGGRECAN; CELL ANTIGEN; CHRONDROITINASE ABC; NEUROCAN; NEURON GLIAL ANTIGEN 2; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SIGMA; PROTEOCHONDROITIN SULFATE; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL REGENERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEGRADATION; DOWN REGULATION; ENZYME INHIBITION; FEMALE; MYELINATION; NERVE FIBER; NERVE FIBER GROWTH; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; RNA INTERFERENCE;

CSPG; DEMYELINATION; OLIGODENDROCYTE PROGENITOR CELL; PROTEIN TYROSINE PHOSPHATASE;

AGGRECANS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE PROTEOGLYCANS; GANGLIA, SPINAL; GANGLIOSIDES; GENE EXPRESSION REGULATION; MYELIN BASIC PROTEIN; MYELIN SHEATH; NEUROFILAMENT PROTEINS; OLIGODENDROGLIA; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84877804122     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.04.003     Document Type: Article

References (75)

1. Bandtlow C.E., Zimmermann D.R. Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol. Rev. 2000, 80(4):1267-1290.
2. Barres B.A., Raff M.C., et al. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 1994, 367(6461):371-375.
3. Barritt A.W., Davies M., et al. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 2006, 26(42):10856-10867.
4. Bogler O., Wren D., et al. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 1990, 87(16):6368-6372.
5. Bradbury E.J., Moon L.D., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416(6881):636-640.
6. Bunge R.P., Puckett W.R., et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 1993, 59:75-89.
7. Cafferty W.B., Bradbury E.J., et al. Chondroitinase ABC-mediated plasticity of spinal sensory function. J. Neurosci. 2008, 28(46):11998-12009.
8. Carulli D., Laabs T., et al. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 2005, 15(1):116-120.
9. Coles C.H., Shen Y., et al. Proteoglycan-specific molecular switch for RPTP clustering and neuronal extension. Science 2011, 332(6028):484-488.
10. Crowe M.J., Bresnahan J.C., et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3(1):73-76.
11. De Wit J., De Winter F., et al. Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix. Mol. Cell. Neurosci. 2005, 29(1):40-55.
12. Dergham P., Ellezam B., et al. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 2002, 22(15):6570-6577.
13. Elbashir S.M., Harborth J., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411(6836):494-498.
14. Elchebly M., Wagner J., et al. Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma. Nat. Genet. 1999, 21(3):330-333.
15. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49(6):377-391.
16. Fisher D., Xing B., et al. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J. Neurosci. 2011, 31(40):14051-14066.
17. Fournier A.E., Takizawa B.T., et al. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 2003, 23(4):1416-1423.
18. Fry E.J., Chagnon M.J., et al. Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia 2010, 58(4):423-433.
19. Galtrey C.M., Fawcett J.W. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007, 54(1):1-18.
20. Garcia-Alias G., Lin R., et al. Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp. Neurol. 2008, 210(2):331-338.
21. Garwood J., Heck N., et al. Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth. J. Biol. Chem. 2003, 278(26):24164-24173.
22. Gilbert R.J., McKeon R.J., et al. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol. Cell. Neurosci. 2005, 29(4):545-558.
23. Goto T., Hoshino Y. Electrophysiological, histological, and behavioral studies in a cat with acute compression of the spinal cord. J. Orthop. Sci. 2001, 6(1):59-67.
24. Guest J.D., Hiester E.D., et al. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 2005, 192(2):384-393.
25. Harauz G., Ladizhansky V., et al. Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry 2009, 48(34):8094-8104.
26. Hartmann U., Maurer P. Proteoglycans in the nervous system-the quest for functional roles in vivo. Matrix Biol. 2001, 20(1):23-35.
27. Hrabetova S., Masri D., et al. Calcium diffusion enhanced after cleavage of negatively charged components of brain extracellular matrix by chondroitinase ABC. J. Physiol. 2009, 587(Pt. 16):4029-4049.
28. Ibarrola N., Mayer-Proschel M., et al. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 1996, 180(1):1-21.
29. Ishibashi T., Dakin K.A., et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49(6):823-832.
30. Johnson K.G., Van Vactor D. Receptor protein tyrosine phosphatases in nervous system development. Physiol. Rev. 2003, 83(1):1-24.
31. Johnson W.E., Caterson B., et al. Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 2002, 46(10):2658-2664.
32. Jones L.L., Margolis R.U., et al. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 2003, 182(2):399-411.
33. Kantor D.B., Chivatakarn O., et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44(6):961-975.
34. Keirstead H.S., Levine J.M., et al. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998, 22(2):161-170.
35. Kuboyama K., Fujikawa A., et al. Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination. PLoS One 2012, 7(11):e48797.
36. Kwok J.C., Afshari F., et al. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor. Neurol. Neurosci. 2008, 26(2-3):131-145.
37. Lemons M.L., Sandy J.D., et al. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury. J. Neurosci. 2001, 21(13):4772-4781.
38. Lemons M.L., Sandy J.D., et al. Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord. Exp. Neurol. 2003, 184(2):981-990.
39. Li G.L., Farooque M., et al. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol. 1999, 98(5):473-480.
40. Liu X.Z., Xu X.M., et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 1997, 17(14):5395-5406.
41. Liu S., Qu Y., et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(11):6126-6131.
42. Liu B.P., Cafferty W.B., et al. Extracellular regulators of axonal growth in the adult central nervous system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361(1473):1593-1610.
43. Massey J.M., Amps J., et al. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp. Neurol. 2008, 209(2):426-445.
44. Mehta N.R., Lopez P.H., et al. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J. Biol. Chem. 2007, 282(38):27875-27886.
45. Monnier P.P., Sierra A., et al. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell. Neurosci. 2003, 22(3):319-330.
46. Moon L.D., Asher R.A., et al. Relationship between sprouting axons, proteoglycans and glial cells following unilateral nigrostriatal axotomy in the adult rat. Neuroscience 2002, 109(1):101-117.
47. Nashmi R., Fehlings M.G. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience 2001, 104(1):235-251.
48. Ohori Y., Yamamoto S., et al. Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J. Neurosci. 2006, 26(46):11948-11960.
49. Park E., Liu Y., et al. Changes in glial cell white matter AMPA receptor expression after spinal cord injury and relationship to apoptotic cell death. Exp. Neurol. 2003, 182(1):35-48.
50. Patel J., Balabanov R. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. Int. J. Mol. Sci. 2012, 13(8):10647-10659.
51. Polverini E., Rangaraj G., et al. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications. Biochemistry 2008, 47(1):267-282.
52. Properzi F., Asher R.A., et al. Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury. Biochem. Soc. Trans. 2003, 31(2):335-336.
53. Ranjan M., Hudson L.D. Regulation of tyrosine phosphorylation and protein tyrosine phosphatases during oligodendrocyte differentiation. Mol. Cell. Neurosci. 1996, 7(5):404-418.
54. Rhodes K.E., Fawcett J.W. Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?. J. Anat. 2004, 204(1):33-48.
55. Sapieha P.S., Duplan L., et al. Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol. Cell. Neurosci. 2005, 28(4):625-635.
56. Shen Y., Tenney A.P., et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326(5952):592-596.
57. Sherman L.S., Back S.A. A 'GAG' reflex prevents repair of the damaged CNS. Trends Neurosci. 2008, 31(1):44-52.
58. Siebert J.R., Osterhout D.J. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes. J. Neurochem. 2011, 119(1):176-188.
59. Siebert J.R., Stelzner D.J., et al. Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells. Exp. Neurol. 2011, 231(1):19-29.
60. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5(2):146-156.
61. Smith P.M., Jeffery N.D. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 2006, 16(2):99-109.
62. Smith G.S., De Avila M., et al. Proline substitutions and threonine pseudophosphorylation of the SH3 ligand of 18.5-kDa myelin basic protein decrease its affinity for the Fyn-SH3 domain and alter process development and protein localization in oligodendrocytes. J. Neurosci. Res 2012, 90(1):28-47.
63. Stallcup W.B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 2002, 31(6-7):423-435.
64. Stevens B., Porta S., et al. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 2002, 36(5):855-868.
65. Syed Y.A., Hand E., et al. Inhibition of CNS remyelination by the presence of semaphorin 3A. J. Neurosci. 2011, 31(10):3719-3728.
66. Tang X., Davies J.E., et al. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J. Neurosci. Res. 2003, 71(3):427-444.
67. Tester N.J., Howland D.R. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp. Neurol. 2008, 209(2):483-496.
68. Thompson K.M., Uetani N., et al. Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension. Mol. Cell. Neurosci. 2003, 23(4):681-692.
69. Thomson C.E., Anderson T.J., et al. The early phenotype associated with the jimpy mutation of the proteolipid protein gene. J. Neurocytol. 1999, 28(3):207-221.
70. Wang P.S., Wang J., et al. Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination. J. Biol. Chem. 2009, 284(48):33692-33702.
71. Wang P.S., Wang J., et al. Loss of protein-tyrosine phosphatase alpha (PTPalpha) increases proliferation and delays maturation of oligodendrocyte progenitor cells. J. Biol. Chem. 2012, 287(15):12529-12540.
72. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 1998, 18(2):601-609.
73. Yamaguchi Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol. Life Sci. 2000, 57(2):276-289.
74. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7(8):617-627.
75. Yu K., Rong W., et al. Neurophysiological evidence of spared upper motor conduction fibers in clinically complete spinal cord injury: discomplete SCI in rats. J. Neurol. Sci. 2001, 189(1-2):23-36.